Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3415946
Max Phase: Preclinical
Molecular Formula: C15H20BrNS
Molecular Weight: 326.30
Molecule Type: Small molecule
Associated Items:
ID: ALA3415946
Max Phase: Preclinical
Molecular Formula: C15H20BrNS
Molecular Weight: 326.30
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Brc1ccc(CNC23CC4CC(CC(C4)C2)C3)s1
Standard InChI: InChI=1S/C15H20BrNS/c16-14-2-1-13(18-14)9-17-15-6-10-3-11(7-15)5-12(4-10)8-15/h1-2,10-12,17H,3-9H2
Standard InChI Key: IEDXEJPASCHMKZ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 326.30 | Molecular Weight (Monoisotopic): 325.0500 | AlogP: 4.57 | #Rotatable Bonds: 3 |
Polar Surface Area: 12.03 | Molecular Species: BASE | HBA: 2 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 1 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 9.68 | CX LogP: 4.47 | CX LogD: 2.23 |
Aromatic Rings: 1 | Heavy Atoms: 18 | QED Weighted: 0.86 | Np Likeness Score: -1.34 |
1. Rey-Carrizo M, Gazzarrini S, Llabrés S, Frigolé-Vivas M, Juárez-Jiménez J, Font-Bardia M, Naesens L, Moroni A, Luque FJ, Vázquez S.. (2015) New polycyclic dual inhibitors of the wild type and the V27A mutant M2 channel of the influenza A virus with unexpected binding mode., 96 [PMID:25899336] [10.1016/j.ejmech.2015.04.030] |
2. Hu Y, Hau RK, Wang Y, Tuohy P, Zhang Y, Xu S, Ma C, Wang J.. (2018) Structure-Property Relationship Studies of Influenza A Virus AM2-S31N Proton Channel Blockers., 9 (11): [PMID:30429954] [10.1021/acsmedchemlett.8b00336] |
Source(1):